Skip to main content
. 2019 Jan 2;17(3):2802–2808. doi: 10.3892/ol.2019.9882

Figure 4.

Figure 4.

FLOT2 expression is association with the survival rate of patients with colorectal cancer. (A) OS and (B) 5-year DFS rates for cases with high FLOT2 expression compared with those for cases with low FLOT2 expression for all patients. (C) OS rate for cases with high FLOT2 expression compared with cases with low FLOT2 expression for patients with pT1-2 grade tumors. (D) OS rate for cases with high FLOT2 expression compared with that for cases with low FLOT2 expression for patients with pT3-4 grade tumors. (E) OS rate for cases at early clinical stages (AJCC stage I–II) with high FLOT2 expression compared with those for cases with low FLOT2 expression levels. (F) OS rate for cases at late stages (AJCC stage III–IV) with high FLOT2 expression levels compared with those for cases with low FLOT2 expression. FLOT2, flotillin-2; OS, overall survival; DFS, disease-free survival.